Role of miRNAs in ALK(+) and ALK(-) anaplastic large cell lymphoma

Hamacher, F, Laimer, D, Scheideler, M, Trajanoski, Z, Egger, G, Kenner, L, Greil, R, Merkel, O ONKOLOGIE. 2010, 33: 209-209.

HETEROGENEOUS EXPRESSION PATTERN OF HEDGEHOG SIGNALLING PATHWAY IN HEMATOPOIESIS OF MYELODYSPLASTIC SYNDROME

Neureiter, D, Kemmerling, R, Alinger, B, Kiesslich, T, Faber, V, Stocher, M, Pleyer, L, Greil, R, Dietz, O HAEMATOL-HEMATOL J. 2010, 95: 375-375.

Is Liposome Encapsulated Doxorubicin Able to Reduce the Cardiotoxicity of Doxorubicin In the Treatment of DLBCL? A Randomised Study by the Austrian Working Party of Medical Oncology (AGMT-Study NHL-14)

Fridrik, M, Petzer, AL, Keil, F, Willenbacher, W, Jager, U, Lang, A, Andel, J, Krieger, O, Oberaigner, W, Greil, R BLOOD. 2010, 116(21): 736-737.

Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation.

Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, Pinon J, Egle A, Villunger A. Genes Dev. 2010 Aug 1,24(15):1602-7. doi: 10.1101/gad.1940210.

Activity of Azacitidine in 26 Unselected, Consecutive CMML Patients Included in the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group

Pleyer, L, Stauder, R, Burgstaller, S, Schreder, M, Tinchon, C, Pfeilstocker, M, Steinkirchner, S, Melchardt, T, Mitrovic, M, Girschikofsky, M, Lang, A, Krippl, P, Egle, A, Sliwa, T, Linkesch, W, Fridrik, MA, Greil, R BLOOD. 2011, 118(21): 747-747.

CD44-hyaluronan interactions in the pathophysiology of chronic lymphocytic leukemia – regulation by cell activation

Girbl, T, Asslaber, D, Brachtl, G, Denk, U, Weiss, L, Naor, D, Greil, R, Hartmann, TN ONKOLOGIE. 2011, 34: 140-140.

A Combination of Fludarabine/Rituximab with Escalating Doses of Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL): The REVLIRIT CLL5 AGMT Phase I/II Study, Clinical and Exploratory Analyses of Induction Results

Egle, A, Steurer, M, Gassner, F, Geisberger, R, Melchardt, T, Weiss, L, Fridrik, MA, Thaler, J, Lang, A, Greil, R BLOOD. 2011, 118(21): 135-136.

Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.

Weiss L, Melchardt T, Egle A, Grabmer C, Greil R, Tinhofer I. Cancer. 2011 May 15,117(10):2163-9. doi: 10.1002/cncr.25752. Epub 2010 Nov 18.

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.

Brachtl G, Sahakyan K, Denk U, Girbl T, Alinger B, Hofbauer SW, Neureiter D, Hofbauer JP, Egle A, Greil R, Hartmann TN. PLoS One. 2011,6(8):e23758. doi: 10.1371/journal.pone.0023758. Epub 2011 Aug 18.

Raltegravir in pregnancy: a case series presentation.

Taylor N, Touzeau V, Geit M, Gisinger M, Egle A, Greil R, Rieger A, Zangerle R. Int J STD AIDS. 2011 Jun,22(6):358-60. doi: 10.1258/ijsa.2011.010469.